|
FKBP1AP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.267640E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.416840E-03 |
| Normal-vs-Stage2 |
9.407800E-02 |
| Normal-vs-Stage3 |
5.234000E-01 |
| Normal-vs-Stage4 |
4.335400E-01 |
| Stage1-vs-Stage2 |
5.630800E-01 |
| Stage1-vs-Stage3 |
1.459800E-02 |
| Stage1-vs-Stage4 |
4.584000E-02 |
| Stage2-vs-Stage3 |
2.435600E-01 |
| Stage2-vs-Stage4 |
3.439200E-01 |
| Stage3-vs-Stage4 |
8.450200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.478400E-02 |
| Normal-vs-AfricanAmerican |
1.072480E-02 |
| Normal-vs-Asian |
1.032150E-01 |
| Caucasian-vs-AfricanAmerican |
1.036790E-01 |
| Caucasian-vs-Asian |
8.064100E-02 |
| AfricanAmerican-vs-Asian |
4.643600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.497600E-03 |
| Normal-vs-Female |
1.047990E-01 |
| Male-vs-Female |
3.958600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.691960E-01 |
| Normal-vs-Age(41-60Yrs) |
1.236460E-03 |
| Normal-vs-Age(61-80Yrs) |
3.011400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.763400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.117800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.867000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.534400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.038800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.754600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.575400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.600100E-02 |
| Normal-vs-Grade 2 |
2.438800E-03 |
| Normal-vs-Grade 3 |
1.807150E-01 |
| Normal-vs-Grade 4 |
2.333000E-01 |
| Grade 1-vs-Grade 2 |
4.992200E-01 |
| Grade 1-vs-Grade 3 |
1.031820E-01 |
| Grade 1-vs-Grade 4 |
1.612810E-01 |
| Grade 2-vs-Grade 3 |
4.364200E-02 |
| Grade 2-vs-Grade 4 |
1.785390E-01 |
| Grade 3-vs-Grade 4 |
8.501800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.957990E-02 |
| Normal-vs-ccB subtype |
1.162200E-01 |
| ccA subtype-vs-ccB subtype |
4.234400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.630800E-01 |
| Normal-vs-N1 |
9.067400E-01 |
| N0-vs-N1 |
5.661200E-01 |
|
|
